Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PhRMA Wants Medication Adherence Coalition To Address Communication Restrictions

This article was originally published in The Pink Sheet Daily

Executive Summary

At the Council for Affordable Health Coverage’s event to launch its Prescription for Healthy America campaign, PhRMA President and CEO John Castellani says opening up the ability of drug manufacturers to communicate about their products could help improve medication adherence.

You may also be interested in...

Brand Drug Marketing Could Get Big Boost From Electronic Health Records

Pharmaceutical companies are looking to electronic health records as a key channel to promote brand products and their related services, a panel of pharma execs at the PharmEHR Summit said.

Drug Substitution Language In E-Health Record Regs Concerns PhRMA

The Pharmaceutical Research and Manufacturers of America and drug manufacturers offer comments on HHS’ proposed next-stage requirements for electronic health records, which physicians and hospitals will have to meet in order to qualify for incentive payments for the meaningful use of EHRs.

Drug Communication Via EHRs Will Improve Rx Adherence, Despite Lack Of HHS Standard, Official Says

Although a specific criterion directly measuring medication adherence is not part of the meaningful use standard for electronic health records, they offer tools to help ensure patients take their medications.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts